Order Article Reprints

Shoemaker K, Soboleva K, Branche A, Shankaran S, Theodore DA, Bari M, Ezeh V, Green J, Kelly E, Lan D, et al. Long-Term Safety and Immunogenicity of AZD1222 (ChAdOx1 nCoV-19): 2-Year Follow-Up from a Phase 3 Study. Vaccines. 2024; 12(8):883. https://doi.org/10.3390/vaccines12080883

Shoemaker, Kathryn, Karina Soboleva, Angela Branche, Shivanjali Shankaran, Deborah A. Theodore, Muhammad Bari, Victor Ezeh, Justin Green, Elizabeth Kelly, Dongmei Lan, and et al. 2024. "Long-Term Safety and Immunogenicity of AZD1222 (ChAdOx1 nCoV-19): 2-Year Follow-Up from a Phase 3 Study" Vaccines 12, no. 8: 883. https://doi.org/10.3390/vaccines12080883

Shoemaker, K., Soboleva, K., Branche, A., Shankaran, S., Theodore, D. A., Bari, M., Ezeh, V., Green, J., Kelly, E., Lan, D., Olsson, U., Saminathan, S., Shankar, N. K., Villegas, B., Villafana, T., Falsey, A. R., & Sobieszczyk, M. E. (2024). Long-Term Safety and Immunogenicity of AZD1222 (ChAdOx1 nCoV-19): 2-Year Follow-Up from a Phase 3 Study. Vaccines, 12(8), 883. https://doi.org/10.3390/vaccines12080883